Trial Profile
Quality of life in patients with advanced idiopathic Parkinson's disease under L‐dopa/carbidopa duodenal infusion therapy and their caregivers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Nov 2020
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary) ; Antidepressants; Antipsychotics
- Indications Parkinson's disease
- Focus Therapeutic Use
- 21 Aug 2015 New trial record
- 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.